{
 "PrintNo":"A9149","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-01-31T10:17:57.511868Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-31","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-01-31","Chamber":"ASSEMBLY"}],
 "Sponsors":[
  {"ID":1105,"Name":"Pamela J. Hunter","Short":"HUNTER"},{"ID":533,"Name":"Jeffrey Dinowitz","Short":"DINOWITZ"},
  {"ID":633,"Name":"Harry B. Bronson","Short":"BRONSON"}
 ],
 "Title":"Requires health insurance policies and medicaid to cover biomarker testing for certain purposes",
 "Summary":"Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L",
 "ActClause":"AN ACT to amend the insurance law and the social services law, in relation to requiring health insurance policies and medicaid to cover biomarker testing for certain purposes",
 "SameAsPrintNo":"S8147-2021"
}